首页> 外文期刊>The Lancet >Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine.
【24h】

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine.

机译:急性冠状动脉事件的风险和不对称二甲基精氨酸的血清浓度。

获取原文
获取原文并翻译 | 示例
           

摘要

Asymmetrical dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor, which has been suggested to be a novel independent risk factor for endothelial dysfunction and coronary heart disease. We investigated the association of ADMA concentration in serum with risk of acute coronary events. We did a prospective, nested, case-control study in middle-aged men from eastern Finland. In an analysis of men who did not smoke, those who were in the highest quartile for ADMA (>0.62 micromol/L) had a 3.9-fold (95% CI 1.25-12.3, p=0.02) increase in risk of acute coronary events compared with the other quartiles. Our findings suggest that ADMA is a predictor of acute coronary events.
机译:不对称二甲基精氨酸(ADMA)是一种内源性一氧化氮合酶抑制剂,已被认为是内皮功能障碍和冠心病的一种新型独立危险因素。我们调查了血清中的ADMA浓度与急性冠脉事件风险的关系。我们对芬兰东部的中年男性进行了前瞻性,嵌套式病例对照研究。在对不吸烟的男性进行的分析中,ADMA最高四分位数(> 0.62 micromol / L)的男性发生急性冠脉事件的风险增加了3.9倍(95%CI 1.25-12.3,p = 0.02)与其他四分位数相比。我们的发现表明,ADMA是急性冠状动脉事件的预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号